Clinical Trial Results
Clinical Trial
Results
Research Sponsor: AstraZeneca AB
Drugs Studied: Exenatide (BydureonÂ®)
National Clinical Trial #: NCT02533453
Protocol #: D5551L00018
Study Date: January 2016 to January 2017
Short Study Title: A study to learn if exenatide is safe and how well
it works in patients with type 2 diabetes
Thank you!
As a clinical study participant, you belong to a large community of participants
around the world. You help researchers answer important health questions and
discover new medical treatments.
Thank you for taking part in this clinical study for the drug exenatide. This is an
approved drug for treating type 2 diabetes. You and all of the participants helped
researchers learn if exenatide is effective and if it causes any medical problems.
AstraZeneca AB, the sponsor of this study, thanks you for your help and thinks
it is important for you to know the results of your study. An independent
non-profit organization called CISCRP prepared this summary of the study
results for you with the help of a medical writing organization.
We hope it helps you understand and feel proud of your important role in
medical research. If you have questions about the results, please speak with
the study doctors or staff at your study site.
1